Trials / Not Yet Recruiting
Not Yet RecruitingNCT06754865
Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data
A Muulticenter, Open, Non-interventional, Retrospective Cohort Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,140 (estimated)
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the effect of Xiyanping injection on the treatment course of intravenous antibiotics for acute exacerbation of chronic obstructive pulmonary disease based on real-world clinical data, and to provide guidance and basis for the clinical application of Xiyanping injection combined with antibiotics in the treatment of acute exacerbation of chronic obstructive pulmonary disease.The secondary objectives is to evaluate the effect of Xiyanping injection on the indicators of acute exacerbation of inflammation and symptom improvement of chronic obstructive pulmonary disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xiyanping injection+ antibiotic | Xiyanping injection+ antibiotic |
| DRUG | Antibiotic | Antibiotic |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2025-11-01
- Completion
- 2025-11-01
- First posted
- 2025-01-01
- Last updated
- 2025-01-01
Source: ClinicalTrials.gov record NCT06754865. Inclusion in this directory is not an endorsement.